Osteopontin is a ligand for the α4β1 integrin

Journal of Cell Science

Volumn 111, Issue 9, 1998, Pages 1165-1174

  Bayless, Kayla J ^a   Meininger, Gerald A ^a   Scholtz, J Martin ^b   Davis, George E ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Adhesion; Injury; Integrin; Leukocyte; Osteopontin; 4 1

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN; CALCIUM ION; INTEGRIN; LIGAND; MAGNESIUM ION; OSTEOPONTIN; PEPTIDE; PROTEIN SUBUNIT; THROMBIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CELL LINE; CELL STRAIN HL 60; CONTROLLED STUDY; ENDOTHELIUM CELL; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MILK; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

BOVINAE;

EID: 0031802697     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Akiyama, S. K., Yamada, S. S., Chen, W. T. and Yamada, K. M. (1989). Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly and cytoskeletal organization. J. Cell Biol. 109, 863-875.
2. 7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin and lymphocyte aggregation. J. Immunol 153, 3847-3861.
3. Bayless, K. J., Davis, G. E. and Meininger, G. A. (1997). Isolation and biological properties of osteopontin from bovine milk. Prot. Expression Purif. 9, 309-314.
4. Carlos, T. M. and Harlan, J. M. (1994). Leukocyte-endothelial adhesion molecules. Blood 84, 2068-2101.
5. Clements, J. M., Newham, P., Shepherd, M., Gilbert, R., Dudgeon, T. J., Needham, L. A., Edwards, R. M., Berry, L., Brass, A., Humphries, M. J. et al. (1994). Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV site in fibronectin. J. Cell Sci. 107, 2127-2135.
6. Davis, G. E. (1992). The Mac-1 and p150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp. Cell Res. 200, 242-252.
7. Davis, G. E. and Camarillo, C. W. (1993). Regulation of integrin-mediated myeloid cell adhesion to fibronectin: influence of disulfide reducing agents. divalent cations and phorbol ester. J. Immunol. 151, 7138-7150.
8. 1 integrin can mediate leukocyte adhesion to casein and denatured protein substrates. J. Leuk. Biol. 62, 318-328.
9. 4 and VCM-1 during smooth muscle cell differentiation. Circ. Res. 80, 159-169.
10. Eddy, A. A., Giachelli, C. M., with technical assistance of McCullough, L. and Liu, E. (1995). Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kid. Int. 47, 1546-1557.
11. Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyi, S., Hemler, M. E. and Lobb, R. R. (1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from VLA-4/fibronectin binding site. Cell 60, 577-584.
12. 7, on human leukocytes. J. Immunol. 153, 517-528.
13. Giachelli, C. M., Bae, N., Lombardi, D. M., Majesky, M. W. and Schwartz, S. M. (1991). Molecular cloning and characterization of 2B7. a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2ar). Biochem. Biophys. Res. Commun. 177, 867-873.
14. Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E. and Schwartz, S. M. (1993). Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92, 1686-1696.
15. Giachelli, C. M., Pichler, R., Lombardi, D., Denhardt, D. T., Alpers, C. E., Schwartz, S. M. and Johnson, R. J. (1994). Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kid. Int. 45, 515-524.
16. 1. Cell. 60, 53-61.
17. Hirota, S., Imakita, M., Kohri, K., Ito, A., Morii, E., Adachi, S., Kim, H. M., Kitamura, Y., Yutani, C. and Nomura, S. (1993). Expression of osteopontin mRNA by macrophages in atherosclerotic plaques. Am. J. Pathol. 143, 1003-1008.
18. 5. J. Biol. Chem. 270, 26232-26238.
19. 3. J. Biol. Chem. 270, 9917-9925.
20. Humphries, M. J., Komoriya, A., Akiyama, S. K., Olden, K. and Yamada, K. M. (1987). Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J. Biol. Chem. 262, 6886-6892.
21. Hynes, R. O. (1992). Integrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11-25.
22. Ikeda, T., Shirasawa, T., Esaki, Y., Yoshiki, S. and Hirokawa, K. (1993). Osteopontin mRNA is expressed by smooth muscle cell-derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 92, 2814-2820.
23. Jones, E. Y., Harlos, K., Bottomley, M. J., Robinson, R. C., Driscoll, P. C., Edwards, R. M., Clements, J. M., Dudgeon, T. J. and Stuart, D. I. (1995). Crystal structure of an integrin-binding fragment of VCAM-1 at 1.8 A resolution. Nature 373, 539-544.
24. Katagiri, Y. U., Murakami, M., Mori, K., Iizuka, J., Hara, T., Tanaka, K., Jia, W. Y., Chambers, A. F. and Uede, T. (1996). Non-RGD domains of osteopontin promote cell adhesion without involving alpha-v integrins. J. Cell. Biochem. 62, 123-131.
25. 4 integrins. J. Mol. Med. 73, 347-354.
26. Komoriya, A., Green, L. J., Mervic, M., Yamada, S. S., Yamada, K. M. and Humphries, M. J. (1991). The minimal essential sequence for a major cell type-specific adhesion site (CS-1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J. Biol. Chem. 266, 15075-15079.
27. Kovach, N. L., Carlos, T. M., Yee, E. and Harlan, J. M. (1992). A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J. Cell Biol. 116, 499-509.
28. Larson, R. S., Corbi, A. L., Berman, L. and Springer, T. (1989). Primary structure of the leukocyte function-associated molecule-1 α subunit: an integrin with an embedded domain defining a protein superfamily. J. Cell Biol. 108, 703-712.
29. Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M. and Giachelli, C. M. (1994). Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 74, 214-224.
30. 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ. Res. 77, 665-672.
31. Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M. and Giachelli, C. M. (1995b). The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J. Clin. Invest. 95, 713-724.
32. 4 integrins in vivo. J. Clin. Invest. 94, 1722-1728.
33. Masumoto, A. and Hemler, M. E. (1993). Multiple activation states of VLA-4. J. Biol. Chem. 268, 228-234.
34. 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266, 20369-20374.
35. Molossi, S., Elices, M., Arrhenius, T., Diaz, R., Coulber, C. and Rabinovitch, M. (1995). Blockade of VLA-4 integrin binding to fibronectin with CS-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95, 2601-2610.
36. 1 in COOH-terminal heparin-binding domain of fibronectin. EMBO J. 10, 4089-4095.
37. 1. J. Biol. Chem. 266, 3579-3585.
38. Murry, C. E., Giachelli, C. M., Schwartz, S. M. and Vracko, R. (1994). Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145, 1450-1462.
39. Nasu, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S. and Yamamoto, S. (1995). Expression of wild-type and mutated rabbit osteopontin in Escherichia coli and their effects on adhesion and migration of P388DI cells. Biochem. J. 307, 257-265.
40. O'Brien, E. R., Garvin, M. R., Stewart, D. K., Hinohara, T., Simpson, J. B., Schwartz, S. M. and Giachelli, C. M. (1994). Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14, 1648-1656.
41. Oldberg, A., Franzen, A. and Heinegard, D. (1986). Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp sequence. Proc. Nat. Acad. Sci. USA 83, 8819-8823.
42. 1). J. Cell Biol. 124, 601-608.
43. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. and Gray, T. (1995). How to measure and predict the molar absorption coefficient of a protein. Prot. Sci. 4, 2411-2423.
44. Pichler, R., Giachelli, C. M., Lombardi, D., Pippin, J., Gordon, K., Alpers, C. E., Schwartz, S. M. and Johnson, R. M. (1994). Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am. J. Pathol. 144, 915-926.
45. Pierschbacher, M. D. and Ruoslahti, E. (1984). Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309, 30-33.
46. 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77, 335-347.
47. 3 potentiate bone resorption. J. Biol. Chem. 268, 9901-9907.
48. 1 subunit induces recognition of the RGDS sequence in fibronectin. J. Cell Biol. 126, 271-279.
49. Sanchez-Madrid, F., De Landazuri, M. O., Morago, G., Cebrian, M., Acevedo, A., Bernabeu, C. (1986). VLA-3: a novel polypeptide associated within the VLA molecular complex: cell distribution and biochemical characterization. Eur. J. Immunol. 16, 1343.
50. Senger, D. R. and Perruzzi, C. A. (1996). Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochem. Biophys. Acta 1314, 13-24.
51. Singh, R. P., Patarca, R., Schwartz, J., Singh, P. and Cantor, H. (1990). Definition of a specific interaction between the early T lymphocyte activation (Eta-1) protein and its effect upon macrophages in vivo. J. Exp. Med. 171, 1931-1942.
52. 1 integrin. J. Biol. Chem. 271, 28485-28491.
53. Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
54. 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-I. Cell Reg. 2, 347-355.
55. Van Dijk, S., D'Errico, J. A., Somerman, M. J., Farach-Carson, M. C. and Butler, W. T. (1993). Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J. Bone Miner. Res. 8, 1499-1506.
56. Vonderheide, R. H., Tedder, T. F., Springer, T. A. and Staunton, D. E. (1994). Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J. Cell Biol. 125, 215-222.
57. Wayner, E. A. and Kovach, N. L. (1992). Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J. Cell Biol. 116, 489-497.
58. Wiener, J., Lombardi, D. M., Su, J. E. and Schwartz, S. M. (1996). Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion. J. Vasc. Res. 33, 195-208.
59. Yang, X. D., Karin, N., Tisch, R., Steinman, L. and McDevitt, H. O. (1993). Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and VLA-4 adhesion receptors. Proc. Nat. Acad. Sci. USA 90, 10494-10498.
60. 1 integrin. Nature 356, 63-66.